SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-000998
Filing Date
2022-01-04
Accepted
2022-01-04 17:21:29
Documents
13
Period of Report
2022-01-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm221380d1_8k.htm   iXBRL 8-K 31959
2 EXHIBIT 10.1 tm221380d1_ex10-1.htm EX-10.1 122500
  Complete submission text file 0001104659-22-000998.txt   358520

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20220103_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20220103_pre.xml EX-101.PRE 22614
5 XBRL TAXONOMY EXTENSION SCHEMA syn-20220103.xsd EX-101.SCH 3060
7 EXTRACTED XBRL INSTANCE DOCUMENT tm221380d1_8k_htm.xml XML 3615
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 22507532
SIC: 2834 Pharmaceutical Preparations